Clinical Trial Update: Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating pegylated interferon and ribavirin therapy for chronic hepatitis C genotype 4 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Ain Shams University | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED